Nephrologist, Westmead Hospital Clinician Researcher Westmead Institute for Medical Research

Jen is a transplant nephrologist working at Westmead Hospital and has an active research portfolio in cell therapies and transplant genomics at the Westmead Institute for Medical Research.

Nephrology Consultant
AZ Groeninge Hospital, Kortrijk, Belgium

Dr. Jasper Callemeyn is a physician-scientist and nephrologist at AZ Groeninge Kortrijk and University Hospitals Leuven. His clinical and research work focuses on kidney transplantation and immune-mediated kidney diseases. He completed a PhD on microvascular transplant rejection at the KU Leuven University in Belgium and continued this line of research through an ESOT Transplant Fellowship at the Medical University in Innsbruck, Austria. He is actively involved in The Transplantation Society and European Society for Organ Transplantation, contributing to education, policy, and young professional development.

Director, Kidney Transplant Program
University Hospital Zurich, Division of Nephrology
Zurich, Switzerland

Thomas Schachtner, MD, EMBA (HSG), is a Professor of Internal Medicine at the University of Zurich and has served as Director of the Kidney Transplant Program at the University Hospital Zurich since 2023. He received his MD from Charité – University Medicine Berlin and completed his training in internal medicine and nephrology at the Charité Campus Virchow Clinic. He worked as a clinician-scientist and investigator at the Berlin Institute of Health (BIH) Center for Regenerative Therapies under the mentorship of Professor Petra Reinke. He joined the University Hospital Zurich in 2018. His research focuses on transplantation immunology, with particular emphasis on virus-specific and allo-specific T-cell immunity, and advanced biomarker strategies, including biopsy-based transcript diagnostics.

Senior Physician, Nehrologist
Vienna, Austria

Georg Böhmig, MD, is an associate professor of medicine at the Division of Nephrology and Dialysis, Department of Medicine III at Medical University of Vienna in Vienna, Austria. Dr Böhmig is also the coordinator of the Vienna kidney transplant wait list and of ABO and HLA antibody-incompatible kidney transplantation programs, including the Austrian KPD program. He received his medical degree from the University of Vienna and trained at the Vienna Institute of Immunology. He obtained licenses for internal medicine, nephrology, and intensive care medicine at the Medical University of Vienna. Dr Böhmig’s published works include more than 250 peer-reviewed journal articles with continuous focus on translational research in transplant immunology. Major research interests of his group (VIETAC; Vienna Transplant and Complement Lab) cover diagnostic and therapeutic aspects of antibody-mediated organ allograft rejection. His current projects focus on novel strategies for ex-vivo monitoring of humoral alloresponses and the evaluation of “anti-humoral” treatment strategies, including apheresis (crossmatch conversion, ABO antibody depletion, rejection treatment), proteasome inhibition, and antibodies targeting complement, Interleukin-6 and CD38.

Nephrologist, Paris, France

Valentin Goutaudier is a transplant nephrologist and clinical trial investigator at the Clinical Investigation Center (CIC1418, led by Prof. Jean-Sébastien Hulot) of the Georges Pompidou European Hospital (AP-HP, Paris, France). He obtained an MSc in Immunology in 2016, an MD in Nephrology in 2017, and a PhD in Data Science in 2024 (Université Paris Cité), positioning his work at the interface of transplantation, clinical research, immunology, computational methods, and digital health. His research focuses on therapeutic personalization through data-driven precision medicine tools and innovative biomarkers, particularly in solid organ transplantation and related fields. He served as Co-Chair of the Young Investigator Committee (2016–2020) and currently co-chairs the Artificial Intelligence and Digital Health Committee of the French-Speaking Society of Transplantation (SFT). He is also an active member of European and international organ transplantation societies (ESOT, TTS).

Professor of Internal Medicine
Vice Chair Research, University of Nebraska Medical Center
Omaha, Nebraska, USA

Dr. Roslyn B Mannon is a Professor of Internal Medicine, and Pathology, Microbiology, and Immunology at the University of Nebraska Medical Center, Vice-Chair for Research and Associate Chief of Research in the Division of Nephrology. A Duke-trained nephrologist, Dr. Mannon is a translational investigator focused on late kidney allograft outcomes. She has published over 250 peer-reviewed publications on chronic allograft failure and post-transplant complications and therapeutics. Dr. Mannon is a past president of the American Society of Transplantation and is a Deputy Editor of the American Journal of Transplantation. She is a Trustee of the Banff Foundation for Allograft Pathology, and Medical Director of the Scientific Registry of Transplant Recipients. She has excelled in clinical and translational science and has a lengthy history of advocacy for transplant recipients, being instrumental in the development of the Transplant Therapeutic Consortium. Dr. Mannon achievements have been recognized by the American Society of Transplantation’s Senior Achievement Award in Clinical Transplantation, the American Association of Kidney Patients Medal of Excellence, and the 2026 National Kidney Foundation Award for Transplant Excellence.

Professor, KU Leuven
Nephrologist, UZ Leuven
Leuven, Belgium, EU

Maarten Naesens is a transplant nephrologist at the University Hospitals Leuven. Next to the clinical duties, he performs translational research at the Department of Microbiology, Immunology and Transplantation at the KU Leuven, focusing on risk factors, diagnosis, and impact of kidney transplant rejection. From 2024 onwards, he is Associate Editor of Kidney International, the official journal of the International Society of Nephrology (ISN) and is involved in the organization of the European Society of Organ Transplantation (ESOT) and Banff congresses. He has published more than 300 peer-reviewed articles in the field of kidney transplantation.